SCHEMBL29071609

SCHEMBL29071609

O=Cc1cn(Cc2ccc(F)cc2F)c2ccccc12

nearest known ligand 0.77

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.77
SMN1; SMN2 Q16637 10/20 0.77
HTT P42858 6/20 0.77
LMNA P02545 5/20 0.77
TDP1 Q9NUW8 1/20 0.67
KMT2A Q03164 6/20 0.60
MEN1 O00255 5/20 0.60
MAPT P10636 4/20 0.49
HSP90AA1 P07900 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8690719 0.90 ALDH1A1 (0.76) ALDH1A1SMN1; SMN2HTTLMNATDP1
SCHEMBL15503856 0.87 SMN1; SMN2 (1.00) ALDH1A1SMN1; SMN2HTTLMNATDP1
SCHEMBL4357272 0.86 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2HTTLMNATDP1
SCHEMBL30487286 0.86 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2HTTLMNATDP1
SCHEMBL29277390 0.83 ALDH1A1 (0.58) ALDH1A1SMN1; SMN2HTTLMNATDP1
SCHEMBL8686615 0.83 SMN1; SMN2 (0.55) ALDH1A1SMN1; SMN2HTTLMNATDP1
SCHEMBL8690446 0.81 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2HTTLMNATDP1
SCHEMBL22001749 0.80 ALDH1A1 (0.52) ALDH1A1SMN1; SMN2HTTLMNATDP1
SCHEMBL30487284 0.80 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2HTTLMNATDP1
SCHEMBL29071626 0.80 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2HTTLMNATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116535386-B Cyanoethylene sulfonyl anilide compound and preparation method and medical application thereof 西南大学 2025-05-27 CN disclosed
CN-116535386-A Cyanoethylene sulfonyl anilide compound and preparation method and medical application thereof 西南大学 2023-08-04 CN disclosed